Cargando…
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts
BACKGROUND: Antitumor immunity is highly heterogeneous between individuals; however, underlying mechanisms remain elusive, despite their potential to improve personalized cancer immunotherapy. Head and neck squamous cell carcinomas (HNSCCs) vary significantly in immune infiltration and therapeutic r...
Autores principales: | Woolaver, Rachel A, Wang, Xiaoguang, Krinsky, Alexandra L, Waschke, Brittany C, Chen, Samantha M Y, Popolizio, Vince, Nicklawsky, Andrew G, Gao, Dexiang, Chen, Zhangguo, Jimeno, Antonio, Wang, Xiao-Jing, Wang, Jing Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797305/ https://www.ncbi.nlm.nih.gov/pubmed/33414263 http://dx.doi.org/10.1136/jitc-2020-001615 |
Ejemplares similares
-
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors
por: John, Jessy, et al.
Publicado: (2022) -
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers
por: Chen, Samantha M. Y., et al.
Publicado: (2022) -
Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15(+) Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma
por: Chen, Samantha M. Y., et al.
Publicado: (2020) -
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
por: Wang, Xiaoguang, et al.
Publicado: (2020) -
Unique changes in the TCR repertoire of tumor-infiltrating lymphocytes underlie the synergy of radiotherapy with CTLA-4 blockade
por: Pilones, Karsten, et al.
Publicado: (2014)